Can your Tumor's DNA unlock better cancer care?

NCT ID NCT02215928

First seen Jan 10, 2026 · Last updated Apr 25, 2026 · Updated 11 times

Summary

This study looks at whether analyzing the DNA of a patient's tumor can help doctors choose more effective treatments for advanced cancer. About 100 adults with metastatic solid tumors that have not responded to standard therapy will have their tumor DNA tested. The goal is to see if this approach can identify targeted drug options and improve outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNSPECIFIED ADULT SOLID TUMOR, PROTOCOL SPECIFIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    RECRUITING

    Palo Alto, California, 94305, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.